Large-scale SUS ‘ideal’ to take on COVID-19 vaccine challenge, says ABEC

BioProcess International: ABEC will supply six 4,000 L single-use bioreactors to the Serum Institute of India and says such large-scale systems can produce billions of doses of potential COVID-19 vaccines at reasonable costs. Read the article.